References
- Despotovic JM, Grimes AB. Pediatric ITP: is it different from adult ITP?. Hematology 2014, the American Society of Hematology Education Program Book .2018; (1):405-11.
- Laghmouchi A, Graça NAG, Voorberg J. Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura. Front Immunol. 2021; 12:757192.
- Grace RF, Lambert MP. An update on pediatric ITP: differentiating primary ITP, IPD, and PID. Blood 2022; 140(6):542-55.
- Kochhar M, Neunert C. Immune thrombocytopenia: A review of upfront treatment strategies. Blood Rev 2021; 49:100822.
- Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Advces.2019;3(22) :3780-817.
- Provan D, Semple JW. Recent advances in the mechanisms and treatment of immune thrombocytopenia. EBioMedicine. 2022;76.
- Akram NN, Ibrahim BA, Ali SM, Nori W. Clinical and laboratory characteristics of children with neurological presentations of COVID-19: a single-center experience. J Med Life. 2022; 15:1294–8.
- Choi PYI, Merriman E, Bennett A, et al. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. Medical Journal of Australia.2022; 216(1):43-52.
- Cuker A, Prak ETL, Cines DB. Can immune thrombocytopenia be cured with medical therapy? Semin Thromb Hemost. 2015;41(4) :395-404.
- Akram NN, Abed MY. Indications and Outcome of Albumin Infusion in a Neonatal Population: A Cross-Sectional Study. Journal of Medicinal and Chemical Sciences 2022;5(1): 129-136
- Mithoowani S, Gregory-Miller K, Goy J, et al. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol .2016; 3(10):e489-96.
- Mjali A, Matti BF, Abbas NT, et al. Do we need local guidelines for the diagnosis and management of immune thrombocytopenia in Iraq? Journal of Applied Hematology 2023;14(2):146-56.
- Ghani S, Baaker R, Akram N. Significance of extreme leukocytosis in evaluation of febrile children aged 3-36 months: A single center experience. Iraqi Journal of Hematology 2016;5(2):167-72.
- I Alezzi J, S. AlKhateeb M, Wisam Hassan E. The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP. Diyala Journal of Medicine. 2019; 17:85–92.
- Jesudas R, Takemoto CM. Where have all the platelets gone? HIT, DIC, or something else? Hematology. 2023(1):43-50.
- Allegra A, Cicero N, Mirabile G, Giorgianni CM, Gangemi S. Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia. Int J Mol Sci. 2023;24 (5):4438.
- Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. Journal of Pediatrics. 2002;141 (5):683-8.
- Wei Y, Ji X Bin, Wang YW, et al. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: A prospective multicenter randomized trial. Blood 2016;127(3):296-302.
- Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. New England Journal of Medicine. 1994; 330(22):1560-4.
- Cydulka RK. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. Ann Emerg Med . 2004;43(5):676-7.
- Cheng Y, Wong RS, Soo YO, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. New England Journal of Medicine. 2003; 349(9):831-6.
- Jaime-Pérez JC, Aguilar-Calderón P, Jiménez-Castillo RA, Ramos-Dávila EM, Salazar-Cavazos L, Gómez-Almaguer D. Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center. Ann Hematol. 2020; 99:2513-20.
- Alakkas Z, Alzaedi OA, Somannavar SS, et al. Steroid-induced diabetes ketoacidosis in an immune thrombocytopenia patient: A case report and literature review. American Journal of Case Reports 2020;21:e923372-1.
- Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-66.
- Fish JD, Lipton JM, Lanzkowsky P. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. eBook. Academic Press, 2021:1401.
- Mazzucconi MG, Fazi P, Bernasconi S, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood. 2007;109(4):1401-7.
- Akram NN, Jaafar MM, Abdulqader SK, et al. Clinical Characteristics and Therapeutic Management of Osteogenesis Imperfecta in Iraqi Children. Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219 ) 2023;5:S189-194.